Research activities:

• Work package leader and steering committee member for DARE-NL, the Dutch infrastructure for cancer-specific ATMP research. Made possible by a grant from the Dutch Cancer Society. Please visit our web page.
• Workstream and work package leader for Oncode Accelerator, the Preclinical Accelerator for Cancer Treatment. Made possible by a grant from the Dutch National Growth Fund. Please visit our web page.
• Collaborator (co-supervisor of a PhD candidate) within the Cure4Life consortium that investigates a platform infrastructure for stem cell-based gene therapies. Made possible by a grant from the Dutch Research Agenda NWA. Please visit our web page.
• Collaborator (co-supervisor of a PhD candidate) within a research project entitled “Streaming comparisons of real-world outcomes with trial results of anticancer drugs”, in collaboration with the St. Antonius Hospital in Utrecht, the Netherlands.
• Many other research projects concerning the safe, effective and sustainable use of innovative medicines, in collaboration with other faculties of Utrecht University, the University Medical Center Utrecht, the Princess Máxima Center, the Dutch Medicines Evaluation Board, the European Medicines Agency, the National Institute for Public Health and the Environment, Orphanet -part of the French National Institute of Health and Medical Research- and several other national and international medical centers and universities.

Related activities:

• Member of the Faculty Open Science Team of UU's Faculty of Science (FOST) of the Faculty of Science of Utrecht University.
• Chair of the Special Interest Group Cell and Gene Therapy of the International Society for Pharmacoepidemiology (ISPE). See also this video.
• Co-founder and co-chair of the Special Interest Group Advanced Therapies of the Regulatory Science Network Netherlands (RSNN).
• Member of the Committee ATMP of the Dutch Medicines Evaluation Board (MEB).